Celularity CELU Income Statement (2018-2026)

NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT
Reported Financials

Celularity Quarterly Income Statement

Periods 31 quarters
Latest Jun 2026

Celularity reported revenue of $5.43M and net income of $0.71M for the quarter ended Jun 2026, down 5.3% year over year. This income statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
10.62M4.86M5.94M3.78M4.14M4.13M3.94M2.94M3.79M12.11M14.68M12.11M9.30M18.13M11.43M5.74M5.28M4.10M3.85M5.43M
Cost of RevenueCost of Rev
2.31M4.66M4.03M3.18M7.21M5.25M2.00M0.80M3.60M9.61M1.64M2.12M3.88M7.34M3.55M5.24M3.90M7.37M1.45M2.35M
Gross Profit
8.31M0.20M1.91M0.60M-3.08M-1.12M1.93M2.14M0.18M2.50M13.04M9.99M5.41M10.79M7.87M0.49M1.38M-3.27M2.39M3.09M
Operating items
Amortization - Intangibles
0.55M0.55M0.54M0.55M0.55M0.55M0.54M0.55M0.55M0.55M0.55M0.46M0.38M0.38M0.37M0.37M0.35M
Research & DevelopmentR&D
23.77M24.69M21.67M25.35M20.35M10.99M16.95M8.60M5.18M-0.27M5.84M3.80M3.92M3.83M3.73M3.35M4.60M3.35M2.99M2.03M
Selling, General & AdministrativeSG&A
21.64M13.21M16.46M15.57M14.91M19.08M13.93M12.83M10.75M13.07M14.03M15.91M12.65M16.06M14.26M12.63M9.31M15.06M9.17M4.94M
Other Operating ExpensesOther Opex
-45.69M-18.09M9.42M-41.32M-25.48M-43.43M36.92M23.98M87.11M-14.00M2.19M2.58M4.26M7.53M3.92M5.61M4.28M7.75M1.82M2.70M
Operating ExpensesOpex
-0.28M19.81M47.55M-0.40M9.78M-13.36M67.81M45.41M103.04M-1.20M22.06M22.29M20.82M27.41M21.91M21.60M18.18M26.16M13.98M9.67M
Operating IncomeOp. Inc
10.90M-14.95M-41.61M4.18M-5.65M17.49M-63.87M-42.48M-99.26M13.32M-7.38M-10.18M-11.53M-9.28M-10.49M-15.86M-12.90M-22.06M-10.13M-4.24M
EBIT
10.90M-14.95M-41.61M4.18M-5.65M17.49M-63.87M-42.48M-99.26M13.32M-7.38M-10.18M-11.53M-9.28M-10.49M-15.86M-12.90M-22.06M-10.13M-4.24M
Non-operating items
Non Operating Interest Expenses
2.44M0.35M0.18M
Goodwill impairment chargesGoodwill Impair.
3.61M29.63M82.71M
Non Operating Investment IncomeNon-Op. Investment Inc.
Interest & Investment IncomeInt & Inv Inc
0.08M0.06M0.01M
Other Non Operating IncomeOther Non Op Inc.
-39.15M-10.00M20.61M-42.76M-7.95M-11.80M-1.78M-1.92M-5.06M117.64M5.33M-7.15M-1.79M7.46M-7.38M-1.15M4.41M5.64M-0.52M-1.08M
Non Operating IncomeNon Op. Inc.
39.04M10.93M-21.25M43.67M10.43M6.96M-0.15M-5.47M5.38M-3.76M-14.64M3.69M-4.57M-4.01M-9.27M-8.66M-10.18M-2.30M11.01M4.94M
Net income details
EBT
49.94M-4.02M-62.87M47.84M4.78M24.45M-64.02M-47.95M-93.88M9.56M-22.01M-6.49M-16.10M-13.29M-19.75M-24.52M-23.08M-24.36M-10.42M0.71M
Tax ProvisionsTaxes
0.02M0.02M-0.02M0.01M0.01M
Profit After TaxPAT
49.94M-4.04M-62.87M47.83M4.80M24.43M-64.02M-47.95M-93.88M9.55M-22.01M-6.49M-16.10M-13.29M-19.75M-24.52M-23.08M-24.36M-10.42M0.71M
Income from Continuing OperationsIncome (Continuing)
10.90M-14.95M-41.61M4.18M-5.65M17.49M-63.87M-42.48M-99.26M13.32M-7.38M-10.18M-11.53M-9.28M-10.49M-15.86M-12.90M-22.06M-10.42M-4.24M
Consolidated Net IncomeConsol Net Inc.
10.90M-14.95M-41.61M4.18M-5.65M17.49M-63.87M-42.48M-99.26M13.32M-7.38M-10.18M-11.53M-9.28M-10.49M-15.86M-12.90M-22.06M-10.42M-4.24M
Income towards Parent CompanyParent Net Inc
49.94M-4.04M-62.87M47.83M4.80M24.43M-64.02M-47.95M-93.88M9.55M-22.01M-6.49M-16.10M-13.29M-19.75M-24.52M-23.08M-24.36M0.87M0.71M
Net Income towards Common StockholdersNet Income
49.94M-4.04M-62.87M47.83M4.80M24.43M-64.02M-47.95M-93.88M9.55M-22.01M-6.49M-16.10M-13.29M-19.82M-24.53M-23.07M-24.39M0.68M0.55M
Additional items
EPS (Basic)
4.69-0.60-4.823.410.341.75-4.12-2.72-4.980.54-1.03-0.30-0.73-0.61-0.84-1.02-0.88-0.950.020.02
EPS (Diluted)
4.04-0.60-4.823.160.321.63-4.12-2.72-4.980.54-1.03-0.30-0.73-0.61-0.84-1.02-0.88-0.950.020.02
Shares Outstanding
10.64M6.71M13.04M14.02M14.27M13.99M15.54M17.66M18.83M17.81M21.44M21.85M21.98M21.89M23.53M24.02M26.35M25.60M29.07M29.20M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
12.36M6.71M13.04M15.13M15.05M14.98M15.54M17.66M18.83M17.81M21.44M21.85M21.98M21.89M23.53M24.02M26.35M25.60M30.30M29.34M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
12.35M6.71M13.77M14.24M14.45M14.89M16.50M18.08M19.37M19.38M21.81M30.57M30.57M30.57M30.57M30.57M28.22M28.84M29.18M29.28M
EBITDA
13.24M-12.35M-39.33M6.49M-3.25M19.92M-61.51M-40.15M-96.91M15.61M-5.22M-8.18M-9.63M-7.40M-8.65M-14.03M-11.08M-20.26M-8.54M-2.70M
Interest ExpensesInt Expense
2.44M0.35M0.18M
Tax Rate
0.04%0.05%0.10%

Celularity Income Statement API

Pull Celularity's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CELU&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY